SMTL ID : 2vwi.1

Structure of the OSR1 kinase, a hypertension drug target

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

homo-tetramer

Ligands

11 x AU: GOLD ION(Non-covalent)(Covalent)

AU.1: 4 residues within 4Å: Chain C: A.66, Q.69, C.70, Q.142 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:C.70 AU.3: 3 residues within 4Å: Chain A: Q.69, C.70, Q.142 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:C.70 AU.4: 2 residues within 4Å: Chain A: P.190, C.191 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:C.191 AU.6: 1 residues within 4Å: Chain D: C.191 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:C.191 AU.8: 2 residues within 4Å: Chain B: C.191, W.192 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:C.191 AU.9: 5 residues within 4Å: Chain B: A.66, Q.69, C.70, N.140, Q.142 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:C.70 AU.10: 4 residues within 4Å: Chain B: A.29, I.48, C.53, L.171 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:C.53 AU.13: 3 residues within 4Å: Chain C: T.189, C.191, W.192 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:C.191 AU.14: 4 residues within 4Å: Chain C: A.27, T.28, K.52, C.53 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:C.53 AU.17: 4 residues within 4Å: Chain D: A.66, C.70, N.140, Q.142 2 PLIP interactions: 1 interactions with chain D, 1 Ligand-Water interactions Metal complexes: D:C.70, H2O.6 AU.18: 4 residues within 4Å: Chain D: T.28, I.48, C.53, L.171 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:C.53

4 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.2: 10 residues within 4Å: Chain A: I.23, G.24, A.29, V.31, V.76, M.92, K.93, L.94, L.95, L.153 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.93, A:L.95 ANP.7: 19 residues within 4Å: Chain B: I.23, G.24, S.25, A.29, V.31, A.44, K.46, M.92, K.93, L.94, L.95, S.99, D.146, K.148, G.150, N.151, L.153, D.164 Ligands: MG.5 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:K.93, B:L.95, B:D.146, B:D.146 Salt bridges: B:K.46 ANP.12: 15 residues within 4Å: Chain A: K.234 Chain C: I.23, G.24, V.31, A.44, K.46, M.92, K.93, L.94, L.95, S.99, K.148, L.153, D.164 Ligands: MG.11 8 PLIP interactions: 6 interactions with chain C, 2 interactions with chain A Hydrogen bonds: C:K.93, C:L.95, C:K.148, C:K.148, C:G.150, A:K.234, A:K.234 Salt bridges: C:K.46 ANP.16: 13 residues within 4Å: Chain D: I.23, G.24, V.31, A.44, K.46, M.92, K.93, L.94, L.95, S.99, L.153, D.164 Ligands: MG.15 5 PLIP interactions: 5 interactions with chain D Hydrogen bonds: D:K.93, D:L.95, D:S.99 Water bridges: D:S.99 Salt bridges: D:K.46

3 x MG: MAGNESIUM ION(Non-covalent)

MG.5: 3 residues within 4Å: Chain B: N.151, D.164 Ligands: ANP.7 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:D.164 MG.11: 3 residues within 4Å: Chain C: N.151, D.164 Ligands: ANP.12 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:D.164 MG.15: 4 residues within 4Å: Chain D: G.150, N.151, D.164 Ligands: ANP.16 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:D.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Villa, F. et al., Structure of the Osr1 Kinase, a Hypertension Drug Target. Proteins (2008)

Release Date

2008-07-08

Peptides

SERINE/THREONINE-PROTEIN KINASE OSR1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

SERINE/THREONINE-PROTEIN KINASE OSR1